Biotech

All Articles

Amgen documents 1st period 3 win for $400M chronic eczema medication

.Amgen has actually discussed (PDF) the 1st period 3 information on its $400 million chronic eczema ...

Biogen, UCB file phase 3 lupus win after stopping working earlier trial

.Biogen and UCB's rely on developing in to stage 3 on the back of an unsuccessful study wants to hav...

Aptadir wishes brand-new RNA preventions can easily turn around tricky cancers

.Italian biotech Aptadir Rehabs has actually launched along with the promise that its own pipe of pr...

Wave surfs DMD effectiveness to regulatory authorities' doors, sending stock up

.Wave Lifestyle Sciences has satisfied its own objective in a Duchenne muscular dystrophy (DMD) stud...

Sanofi plucks brand-new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma layer, using...

Achilles trickles cell therapy plan, prepares for layoffs after missing 'industrial feasibility' objectives

.Achilles Therapeutics has wrecked its technique. The British biotech is actually quiting working on...

Aligos proclaims stage 2 MASH win, lowering liver body fat up to 46%

.Aligos Rehabs is actually advertising a midstage win in metabolic-dysfunction affiliated steatohepa...

Basilea scores $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job building brand new antifungals has gotten a considerable improvement fr...

Capricor sells Europe civil liberties to late-stage DMD treatment for $35M

.Possessing currently scooped up the united state liberties to Capricor Therapeutics' late-stage Duc...

FDA fragments adcomm for Applied's rare health condition drug

.After pushing back the choice date for Applied Rehabs' metabolic disorder medicine govorestat, the ...